Gene · 7481
Papers1,743
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,743
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcription of WNT Genes in Hematopoietic Niche's Mesenchymal Stem Cells in Multiple Myeloma Patients with Different Responses to Treatment. | Genes (Basel) | 2023 | 37239457 | PubTator, text mining | PubMed |
| Rapid Generation of Pulmonary Organoids from Induced Pluripotent Stem Cells by Co-Culturing Endodermal and Mesodermal Progenitors for Pulmonary Disease Modelling. | Biomedicines | 2023 | 37239147 | PubTator, text mining | PubMed |
| Understanding the Wnt Signaling Pathway in Acute Myeloid Leukemia Stem Cells: A Feasible Key against Relapses. | Biology (Basel) | 2023 | 37237497 | PubTator, text mining | PubMed |
| Prostate cancer and bone: clinical presentation and molecular mechanisms. | Endocr Relat Cancer | 2023 | 37226936 | PubTator, text mining | PubMed |
| Mechanistic Regulation of Wnt Pathway-Related Progression of Chronic Obstructive Pulmonary Disease Airway Lesions. | Int J Chron Obstruct Pulmon Dis | 2023 | 37215745 | PubTator, text mining | PubMed |
| Advances in Medicinal Chemistry of Estrogen-related Receptor Alpha (ERRα) Inverse Agonists. | Curr Top Med Chem | 2023 | 37190810 | PubTator, text mining | PubMed |
| Knowledge mapping of extracellular vesicles in wound healing: A bibliometric analysis (2002-2022). | Int Wound J | 2023 | 37183322 | PubTator, text mining | PubMed |
| The Role of Paxillin Aberrant Expression in Cancer and Its Potential as a Target for Cancer Therapy. | Int J Mol Sci | 2023 | 37175948 | PubTator, text mining | PubMed |
| Human pancreatic cancer patients with Epithelial-to-Mesenchymal Transition and an aggressive phenotype show a disturbed balance in Protein Phosphatase Type 2A expression and functionality. | J Transl Med | 2023 | 37170215 | PubTator, text mining | PubMed |
| Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities. | Nat Commun | 2023 | 37164978 | PubTator, text mining | PubMed |
| Enhanced Clinical Utility of Molecular Budding Signature as a Recurrence Risk Determinant in Stage II and III Colon Cancer Patients. | Ann Surg Oncol | 2023 | 37154970 | PubTator, text mining | PubMed |
| Overview of junctional complexes during mammalian early embryonic development. | Front Endocrinol (Lausanne) | 2023 | 37152932 | PubTator, text mining | PubMed |
| In utero exposure to diethylstilbestrol and blood DNA methylation in adult women: Results from a meta-analysis of two cohort studies. | Environ Res | 2023 | 37149030 | PubTator, text mining | PubMed |
| An autophagy-related diagnostic biomarker for uterine fibroids: FOS. | Front Med (Lausanne) | 2023 | 37138755 | PubTator, text mining | PubMed |
| Effects of HDAC inhibitors on neuroblastoma SH-SY5Y cell differentiation into mature neurons via the Wnt signaling pathway. | BMC Neurosci | 2023 | 37127577 | PubTator, text mining | PubMed |
| Metastatic breast tumors downregulate miR-145 regulating the hypoxia-induced vasculogenic mimicry. | Transl Oncol | 2023 | 37121177 | PubTator, text mining | PubMed |
| Stem cell-derived exosomes: emerging therapeutic opportunities for wound healing. | Stem Cell Res Ther | 2023 | 37101197 | PubTator, text mining | PubMed |
| Inhibition of Wnt11 impairs the osteogenesis and aggravates the inflammatory response of human mesenchymal stem cells under LPS-induced inflammatory condition. | Biochem Biophys Res Commun | 2023 | 37087802 | PubTator, text mining | PubMed |
| The lysophosphatidic acid-regulated signal transduction network in ovarian cancer cells and its role in actomyosin dynamics, cell migration and entosis. | Theranostics | 2023 | 37064875 | PubTator, text mining | PubMed |
| Effect and Mechanism of Theaflavins on Fluoride Transport and Absorption in Caco-2 Cells. | Foods | 2023 | 37048308 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7481/papers?page=9